NEW YORK--(BUSINESS WIRE)--BNB Plus Corp. (Nasdaq: BNBX) ("BNBX†or the "Company†), today announced that it has received a $1.2M USD order for LineaDNA, representing the largest LineaDNA order in Company history. The order is an acceleration of an existing customer's annual purchasing cadence, consolidating what was originally planned as a two-year order cycle into an accelerated delivery schedule expected to be completed by May 2026. The order was placed by a global manufacturer of in vitro di. ...

As filed with the Securities and Exchange Commission on December 22, 2025. Registration Statement No. 333-291156 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BNB Plus Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 50 Health Sciences Drive Stony Brook, New York 11790 631-240-8800 (Address, including zip code, and telephone ...

Table of Contents As filed with the Securities and Exchange Commission on October 29, 2025. Registration Statement No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Applied DNA Sciences, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) 50 Health Sciences Drive Stony Brook, New York 11 ...